HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone) (HAL)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01023620 |
|
Recruitment Status
: Unknown
Verified December 2009 by University of Texas Southwestern Medical Center.
Recruitment status was: Recruiting
First Posted
: December 2, 2009
Last Update Posted
: December 2, 2009
|
Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
Takeda Pharmaceuticals North America, Inc.
Information provided by:
University of Texas Southwestern Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | December 2010 |
| Estimated Study Completion Date : | December 2010 |